Home › Funds › Data Collective IV GP, LLC › RXRX

Data Collective IV GP, LLC position in RXRX

RECURSION PHARMACEUTICALCLASS A · Health Care

Data Collective IV GP, LLC reported holding 5,941,120 shares of RXRX (RECURSION PHARMACEUTICALCLASS A) in its Q2 2026 13F filing — a position valued at US$21.8M, representing 27.76% of its reported portfolio and ranking #3 among its reported holdings. Data Collective IV GP, LLC has disclosed RXRX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)5.94M sh
Reported value held$21.80M
Portfolio Weight27.76%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Data Collective IV GP, LLC's RXRX position evolved

Data Collective IV GP, LLC first disclosed a stake in RXRX in Q3 2023 at 5,941,120 shares (US$45.4M). The position peaked in Q1 2024 at 5,941,120 shares, worth US$59.2M. Across 12 filings, Data Collective IV GP, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 5,941,120 shares valued at US$21.8M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 5.94M $45.45M New
Q4 2023 5.94M $58.58M Hold
Q1 2024 5.94M $59.23M Hold
Q2 2024 5.94M $44.56M Hold
Q3 2024 5.94M $39.15M Hold
Q4 2024 5.94M $40.16M Hold
Q1 2025 5.94M $31.43M Hold
Q2 2025 5.94M $30.06M Hold
Q3 2025 5.94M $28.99M Hold
Q4 2025 5.94M $24.30M Hold
Q1 2026 5.94M $18.24M Hold
Q2 2026 5.94M $21.80M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RXRX and 13F data

RXRX (RECURSION PHARMACEUTICALCLASS A) is a Health Care company. 28 other funds we track also report a position in RXRX — the largest reported positions include ARK Invest (US$151.7M), SOFTBANK GROUP CORP. (US$50.0M), MIC Capital Management UK LLP (US$35.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RXRX

All RXRX fund holders →

FAQ

How long has Data Collective IV GP, LLC held RXRX?

Data Collective IV GP, LLC has disclosed RXRX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Data Collective IV GP, LLC's current position in RXRX?

As of Q2 2026, Data Collective IV GP, LLC holds 5.94M shares of RXRX (RECURSION PHARMACEUTICALCLASS A), valued at $21.80M, representing 27.76% of its reported portfolio and ranking #3.

Has Data Collective IV GP, LLC been buying or selling RXRX?

In the latest 13F filing (Q2 2026), Data Collective IV GP, LLC held unchanged its position in RXRX. The position peaked in Q1 2024 at 5.94M shares.

Which other funds hold RXRX?

Other major institutional holders of RXRX include ARK Invest, SOFTBANK GROUP CORP., MIC Capital Management UK LLP, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.